| Reproductive history and renal cell carcinoma |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Oct 1, 2009 |
2009-0172 |
| Estimated Radiation Dose to Participants Receiving Chest X-Rays in the National Lung Screening Trial (NLST) |
Michael Flynn |
Henry Ford Health System |
NLST |
Sep 28, 2009 |
200909-0088 |
| Effects of In-Plane Spatial Resolution on Computer-Aided Diagnosis Features of Small Pulmonary Nodules |
David Gierada |
Washington University |
NLST |
Sep 3, 2009 |
200909-0010 |
| Prospective assessment of thyroid cancer risk and exposure to persistent polyhalogenated aromatic hydrocarbons |
Mary Ward |
NCI, DCEG |
PLCO |
Aug 21, 2009 |
2009-0518 |
| Participant Tracking and Tracing in the PLCO and NLST/LSS Trials |
Pamela Marcus |
NCI, DCP, BRG |
PLCO |
Aug 13, 2009 |
2009-0159 |
| Risk factors for hepatocellular carcinoma in the United States |
Katherine McGlynn |
NCI, DCEG, HREB |
PLCO |
Jul 23, 2009 |
2009-0154 |
| A prospective investigation of the relationship between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of head and neck cancers (HNC) and malignant melanomas (MM) |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jul 23, 2009 |
2009-0035 |
| Serum Melatonin and Subsequent Risk of Prostate Cancer |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 17, 2009 |
2008-0256 |
| Development of a Pancreatic Cancer Risk Prediction Model |
Martin Tammemagi |
Brock University / Henry Ford Health System |
PLCO |
Jul 15, 2009 |
2009-0095 |
| Risk of an Abnormal Suspicious False Positive Screening Exam for Ovarian Cancer in the PLCO Cancer Screening Trial. |
Sarah Nyante |
NCI, DCEG, HREB |
PLCO |
Jul 10, 2009 |
2009-0059 |
| Diet, underlying diseases, reproductive factors and CLL/SLL |
Huei-Ting Tsai |
NCI, DCEG, GEB |
PLCO |
Jun 26, 2009 |
2009-0106 |
| Participant Tracking and Tracing in the PLCO and NLST/LSS Trials |
Pamela Marcus |
National Cancer Institute |
NLST |
Jun 22, 2009 |
200906-0040 |
| Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators: Study 4: Validation using PLCO serial specimens of PLCO Ovarian Cance |
Nicole Urban |
Fred Hutchinson Cancer Research Center |
PLCO |
Jun 19, 2009 |
2009-0504 |
| RISK FACTORS FOR INVASIVE BREAST CANCER BY HORMONE RECEPTOR STATUS AND FOR DUCTAL CARCINOMA IN SITU |
Claudine Isaacs |
Georgetown University |
PLCO |
Jun 18, 2009 |
2009-0121 |
| Prospective evaluation of IGF and IL-6 dysregulation and multiple myeloma |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Jun 10, 2009 |
2009-0506 |
| Chronic Inflammation and Risk of Lung Cancer |
Anil Chaturvedi |
NCI, DCEG, IIB |
PLCO |
Jun 10, 2009 |
2009-0516 |
| PLCO Participant Survey |
Shannon Pretzel |
University of Colorado Health Science Center |
PLCO |
May 28, 2009 |
2009-0116 |
| Determinants of Menopausal Hormone Therapy Use in Women in the PLCO Study |
Bruce Kessel |
Pacific Health Research Institute (Hawaii) |
PLCO |
May 26, 2009 |
2009-0062 |
| Cancer Recurrence after Diagnosis of Clinically Localized Prostate Cancer |
Sarah Daughterty |
NCI, DCEG, OEEB |
PLCO |
May 26, 2009 |
2009-0063 |
| Nomogram predicting the risk bladder cancer and high-grade bladder cancer |
Andrew Stephenson |
Cleveland Clinic |
PLCO |
May 26, 2009 |
2009-0075 |
